What is the price target for CVX stock?
32 analysts have analysed CVX and the average price target is 206.45 USD. This implies a price increase of 11.3% is expected in the next year compared to the current price of 185.49.
NYSE:CVX • US1667641005
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CHEVRON CORP (CVX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-22 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2026-04-17 | BNP Paribas | Upgrade | Neutral -> Outperform |
| 2026-04-13 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-04-09 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-04-02 | Citigroup | Maintains | Buy -> Buy |
| 2026-03-27 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-03-17 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-03-16 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-03-12 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-03-02 | B of A Securities | Maintains | Buy -> Buy |
| 2026-03-02 | Citigroup | Maintains | Buy -> Buy |
| 2026-02-02 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-01-21 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-20 | JP Morgan | Reiterate | Overweight |
| 2026-01-14 | Jefferies | Maintains | Buy -> Buy |
| 2026-01-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-06 | Freedom Capital Markets | Downgrade | Hold -> Sell |
| 2026-01-05 | Bernstein | Maintains | Market Perform -> Market Perform |
| 2026-01-05 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-12 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-12-11 | B of A Securities | Maintains | Buy -> Buy |
| 2025-12-01 | HSBC | Upgrade | Hold -> Buy |
| 2025-11-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-13 | Mizuho | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 196.913B -16.46% | 193.414B -1.78% | 184.432B -4.64% | 217.911B 18.15% | 208.679B -4.24% | 211.123B 1.17% | 189.015B -10.47% | 188.585B -0.23% | |
| EBITDA YoY % growth | 42.46B -27.07% | 41.961B -1.18% | 38.281B -8.77% | 50.543B 32.03% | 53.272B 5.40% | 54.814B 2.89% | 57.759B 5.37% | 57.677B -0.14% | |
| EBIT YoY % growth | 25.134B -40.01% | 24.679B -1.81% | 18.149B -26.46% | 21.742B 19.80% | 25.71B 18.25% | 29.356B 14.18% | 35.059B 19.43% | 35.851B 2.26% | |
| Operating Margin | 12.76% | 12.76% | 9.84% | 9.98% | 12.32% | 13.90% | 18.55% | 19.01% | |
| EPS YoY % growth | 13.13 -30.27% | 10.05 -23.46% | 7.32 -27.16% | 8.64 17.97% | 9.64 11.67% | 11.12 15.29% | 12.30 10.65% | 14.20 15.44% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.33 -38.81% | 3.59 103.01% | 3.23 74.50% | 2.98 95.79% | 2.83 112.01% | 2.88 -19.83% | 3.01 -6.65% | 2.88 -3.24% | 2.95 4.41% | 3.11 7.87% | 3.62 19.98% | 3.26 13.06% |
| Revenue Q2Q % growth | 52.721B 10.74% | 57.867B 29.10% | 55.058B 10.72% | 54.083B 15.38% | 52.32B -0.76% | 52.608B -9.09% | 53.318B -3.16% | 51.922B -4.00% | 50.473B -3.53% | 50.123B -4.72% | 50.95B -4.44% | 48.89B -5.84% |
| EBITDA Q2Q % growth | 10.658B 17.90% | 15.768B 27.45% | 14.935B -21.64% | 13.892B -43.33% | 13.89B 30.32% | 14.381B -8.80% | 15.17B 1.57% | 14.465B 4.12% | 12.97B -6.62% | 13.381B -6.95% | 14.542B -4.14% | 13.725B -5.12% |
| EBIT Q2Q % growth | 4.862B -1.12% | 8.73B 123.56% | 8.518B 77.02% | 7.352B 67.78% | 5.599B 15.16% | 5.927B -32.11% | 5.92B -30.50% | 5.661B -23.00% | 5.545B -0.96% | 4.893B -17.45% | 4.952B -16.35% | 4.828B -14.71% |
All data in USD
32 analysts have analysed CVX and the average price target is 206.45 USD. This implies a price increase of 11.3% is expected in the next year compared to the current price of 185.49.
CHEVRON CORP (CVX) will report earnings on 2026-05-01, before the market open.
The consensus EPS estimate for the next earnings of CHEVRON CORP (CVX) is 1.33 USD and the consensus revenue estimate is 52.72B USD.
The number of analysts covering CHEVRON CORP (CVX) is 32.